Concentrations of autoantibodies correlate with disease severity. Why do some people get so much sicker than others with acute COVID-19? And what causes the neurological symptoms — anosmia, fatigue, encephalopathy — seen in some patients? A team from Yale employed a new technology for finding autoantibodies to 2770 extracellular and […]
Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution […]
Cognitive dysfunction tops the list of neurologic complaints in long-haul COVID-19 patients whose illness wasn’t severe enough for them to be hospitalized, but it isn’t the only problem, new research shows. Researchers who tracked 100 COVID-19 long-haul, nonhospitalized patients from May to November found 85% reported four or more neurologic […]
More than three quarters of Wuhan residents who tested positive for SARS-CoV-2 antibodies had experienced no covid-19 symptoms and just under half developed long lasting neutralising antibodies, show results from the first long term seroprevalence study from the epicentre of the outbreak in China.1 Researchers tested 9542 people from 3556 […]
Three-quarters of patients hospitalized with coronavirus disease 2019 (COVID-19) still had at least 1 symptom 6 months after they became ill, according to recently published follow-up research. The study included 1733 patients who were hospitalized in Wuhan, China, and discharged between January and May 2020. Fatigue and ongoing muscle weakness […]
